House committee approves substitute for bill regarding patient access to breakthrough products
/ 1 min read
Table of Contents
The House Committee on Energy and Commerce has approved a substitute version of the Ensuring Patient Access to Critical Breakthrough Products Act. This means the committee has changed the original text of the bill and is now recommending this new version to the full House of Representatives.
Why it matters: This is a procedural step in the legislative process. While it moves the bill closer to a potential vote in the House, it does not become law unless it passes both chambers and is signed by the President.
Who it affects
- Pharmaceutical companies developing breakthrough medical products
This information comes from Congress.gov regarding a House committee action; readers should consult the official text of the substitute amendment before relying on this information.
Agency: House
Source: Congress.gov — read the official document